Evidence map›Paper›PMID 36678686›Full record

ArticlePharmaceutics2022

Imaging of Gα

Jan H Voss, Haneen Al-Hroub, Robin Gedschold, Jennifer M Dietrich, Evelyn Gaffal, Marieta Toma, Stefan Kehraus, Gabriele M König, Peter Brust, Bernd K Fleischmann and 3 more

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jan H VossPharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, D-53121 Bonn, Germany.
Haneen Al-HroubPharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, D-53121 Bonn, Germany.
Robin GedscholdPharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, D-53121 Bonn, Germany.
Jennifer M DietrichInstitute of Physiology I, Life & Brain Center, Medical Faculty, University of Bonn, D-53127 Bonn, Germany.
Evelyn GaffalDepartment of Dermatology, University Hospital Magdeburg, D-39120 Magdeburg, Germany.ORCID 0000-0002-4639-9841
Marieta TomaInstitute of Pathology, University Hospital Bonn (UKB), Medical Faculty, University of Bonn, D-53127 Bonn, Germany.
Stefan KehrausInstitute for Pharmaceutical Biology, University of Bonn, Nussallee 6, D-53115 Bonn, Germany.
Gabriele M KönigInstitute for Pharmaceutical Biology, University of Bonn, Nussallee 6, D-53115 Bonn, Germany.
Peter BrustDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, D-03418 Leipzig, Germany.ORCID 0000-0001-5555-7058
Bernd K FleischmannInstitute of Physiology I, Life & Brain Center, Medical Faculty, University of Bonn, D-53127 Bonn, Germany.ORCID 0000-0002-9202-8363
Daniela WenzelInstitute of Physiology I, Life & Brain Center, Medical Faculty, University of Bonn, D-53127 Bonn, Germany.
Winnie Deuther-ConradDepartment of Neuroradiopharmaceuticals, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, D-03418 Leipzig, Germany.ORCID 0000-0003-3168-3062
Christa E MüllerPharmaCenter Bonn, Pharmaceutical Institute, Pharmaceutical & Medicinal Chemistry, University of Bonn, D-53121 Bonn, Germany.ORCID 0000-0002-0013-6624
University of Bonn · DEHelmholtz-Zentrum Dresden-Rossendorf · DEUniversity Hospital Magdeburg · DE

Funding

Deutsche Forschungsgemeinschaft FOR2372, MU1665/7-2; WE 4461/2-1 and -2Federal Ministry of Education and Research BIGS DrugS
6 · The paper itself

Abstract

G protein-coupled receptors (GPCRs) transfer extracellular signals across cell membranes by activating intracellular heterotrimeric G proteins. Several studies suggested G proteins as novel drug targets for the treatment of complex diseases, e.g., asthma and cancer. Recently, we developed specific radiotracers, [³H]PSB-15900-FR and [³H]PSB-16254-YM, for the Gαq family of G proteins by tritiation of the macrocyclic natural products FR900359 (FR) and YM-254890 (YM). In the present study, we utilized these potent radioligands to perform autoradiography studies in tissues of healthy mice, mouse models of disease, and human tissues. Specific binding was high, while non-specific binding was extraordinarily low, giving nearly identical results for both radioligands. High expression levels of Gαq proteins were detected in healthy mouse organs showing the following rank order of potency: kidney > liver > brain > pancreas > lung > spleen, while expression in the heart was low. Organ sub-structures, e.g., of mouse brain and lung, were clearly distinguishable. Whereas an acute asthma model in mice did not result in altered Gαq protein expressions as compared to control animals, a cutaneous melanoma model displayed significantly increased expression in comparison to healthy skin. These results suggest the future development of Gαq-protein-binding radio-tracers as novel diagnostics.

Indexed as

asthmaautoradiographyFR900359G protein-coupled receptorsGαq proteinlungmelanomamouse brainradioligandYM-254890

Identifiers

PMID36678686
PMCPMC9865079
OpenAlexW4313327288

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.